Celltrion
068270.KS
#806
Rank
ยฃ21.54 B
Marketcap
ยฃ95.80
Share price
0.11%
Change (1 day)
8.90%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2025 (TTM): ยฃ2.04 Billion

According to Celltrion 's latest financial reports the company's current revenue (TTM ) is ยฃ2.01 Billion. In 2024 the company made a revenue of ยฃ2.05 Billion an increase over the revenue in the year 2023 that were of ยฃ1.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ2.04 B-0.62%
2024 ยฃ2.05 B58.63%
2023 ยฃ1.29 B-10.72%
2022 ยฃ1.44 B18.63%
2021 ยฃ1.22 B4.46%
2020 ยฃ1.17 B58.07%
2019 ยฃ0.74 B5.22%
2018 ยฃ0.70 B11.68%
2017 ยฃ0.62 B33.61%
2016 ยฃ0.47 B33.11%
2015 ยฃ0.35 B22.56%
2014 ยฃ0.28 B130.11%
2013 ยฃ0.12 B-36.8%
2012 ยฃ0.19 B
2010 ยฃ0.10 B40.72%
2009 ยฃ72.38 M45.74%
2008 ยฃ49.66 M